Biochemical characterization of the core structure of alpha-synuclein filaments - PubMed (original) (raw)

. 2002 May 24;277(21):19213-9.

doi: 10.1074/jbc.M110551200. Epub 2002 Mar 13.

Affiliations

• PMID: 11893734
• DOI: 10.1074/jbc.M110551200

Free article

Biochemical characterization of the core structure of alpha-synuclein filaments

Hirotomo Miake et al. J Biol Chem. 2002.

Free article

Abstract

Intracellular filamentous aggregates comprised of alpha-synuclein such as Lewy bodies and glial cytoplasmic inclusions are the defining hallmarks of a subset of neurodegenerative diseases including Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. We have analyzed biochemical and structural properties of alpha-synuclein filaments assembled in vitro or extracted from brains of patients with multiple system atrophy and found that both types of filaments are insoluble to detergents and partially resistant to proteinase K digestion. Immunoelectron microscopy and immunoblot analysis showed that both amino and carboxyl termini of alpha-synuclein in in vitro assembled filaments were degraded by proteinase K treatment, whereas the central portion of alpha-synuclein is resistant to proteinase K and retains filamentous structures. Protein sequencing and mass spectrometric analyses of the proteinase K-resistant, minimal fragment of 7 kDa revealed that amino acid residues 31-109 of alpha-synuclein constitute the core unit of the filaments. These observations suggest that the central half of the alpha-synuclein polypeptide, containing five tandem repeats as well as a part of the carboxyl-terminal acidic region, forms the core structure of alpha-synuclein filaments, which is coated by the amino- and carboxyl-terminal portions at the periphery.

PubMed Disclaimer

Similar articles

• Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation.
  Serpell LC, Berriman J, Jakes R, Goedert M, Crowther RA. Serpell LC, et al. Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4897-902. doi: 10.1073/pnas.97.9.4897. Proc Natl Acad Sci U S A. 2000. PMID: 10781096 Free PMC article.
• Role of alpha-synuclein carboxy-terminus on fibril formation in vitro.
  Murray IV, Giasson BI, Quinn SM, Koppaka V, Axelsen PH, Ischiropoulos H, Trojanowski JQ, Lee VM. Murray IV, et al. Biochemistry. 2003 Jul 22;42(28):8530-40. doi: 10.1021/bi027363r. Biochemistry. 2003. PMID: 12859200
• alpha-Synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy.
  Gai WP, Pountney DL, Power JH, Li QX, Culvenor JG, McLean CA, Jensen PH, Blumbergs PC. Gai WP, et al. Exp Neurol. 2003 May;181(1):68-78. doi: 10.1016/s0014-4886(03)00004-9. Exp Neurol. 2003. PMID: 12710935
• From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.
  Goedert M, Spillantini MG, Serpell LC, Berriman J, Smith MJ, Jakes R, Crowther RA. Goedert M, et al. Philos Trans R Soc Lond B Biol Sci. 2001 Feb 28;356(1406):213-27. doi: 10.1098/rstb.2000.0767. Philos Trans R Soc Lond B Biol Sci. 2001. PMID: 11260802 Free PMC article. Review.
• Amino acid determinants of alpha-synuclein aggregation: putting together pieces of the puzzle.
  Uversky VN, Fink AL. Uversky VN, et al. FEBS Lett. 2002 Jul 3;522(1-3):9-13. doi: 10.1016/s0014-5793(02)02883-1. FEBS Lett. 2002. PMID: 12095610 Review.

Cited by

• Direct observation of the interconversion of normal and toxic forms of α-synuclein.
  Cremades N, Cohen SI, Deas E, Abramov AY, Chen AY, Orte A, Sandal M, Clarke RW, Dunne P, Aprile FA, Bertoncini CW, Wood NW, Knowles TP, Dobson CM, Klenerman D. Cremades N, et al. Cell. 2012 May 25;149(5):1048-59. doi: 10.1016/j.cell.2012.03.037. Cell. 2012. PMID: 22632969 Free PMC article.
• Structural similarity of wild-type and ALS-mutant superoxide dismutase-1 fibrils using limited proteolysis and atomic force microscopy.
  Chan PK, Chattopadhyay M, Sharma S, Souda P, Gralla EB, Borchelt DR, Whitelegge JP, Valentine JS. Chan PK, et al. Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):10934-9. doi: 10.1073/pnas.1309613110. Epub 2013 Jun 18. Proc Natl Acad Sci U S A. 2013. PMID: 23781106 Free PMC article.
• Residue Glu83 plays a major role in negatively regulating alpha-synuclein amyloid formation.
  Waxman EA, Emmer KL, Giasson BI. Waxman EA, et al. Biochem Biophys Res Commun. 2010 Jan 15;391(3):1415-20. doi: 10.1016/j.bbrc.2009.12.079. Epub 2009 Dec 21. Biochem Biophys Res Commun. 2010. PMID: 20026050 Free PMC article.
• Sumoylation inhibits alpha-synuclein aggregation and toxicity.
  Krumova P, Meulmeester E, Garrido M, Tirard M, Hsiao HH, Bossis G, Urlaub H, Zweckstetter M, Kügler S, Melchior F, Bähr M, Weishaupt JH. Krumova P, et al. J Cell Biol. 2011 Jul 11;194(1):49-60. doi: 10.1083/jcb.201010117. J Cell Biol. 2011. PMID: 21746851 Free PMC article.
• Interaction of Proteins Involved in Neuronal Proteinopathies.
  Kulichikhin KY, Malikova OA, Zobnina AE, Zalutskaya NM, Rubel AA. Kulichikhin KY, et al. Life (Basel). 2023 Sep 23;13(10):1954. doi: 10.3390/life13101954. Life (Basel). 2023. PMID: 37895336 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • BioCyc

• Miscellaneous

  • NCI CPTAC Assay Portal